Deflexifol trial: Illawarra-developed chemotherapy drug a success

By Lisa Wachsmuth
Updated June 18 2017 - 7:11pm, first published 6:00pm
Good medicine: Leading Wollongong oncologist Professor Philip Clingan is the co-inventor of a new chemotherapy drug that has proved successful in its first human trials in Wollongong. Picture: Adam McLean
Good medicine: Leading Wollongong oncologist Professor Philip Clingan is the co-inventor of a new chemotherapy drug that has proved successful in its first human trials in Wollongong. Picture: Adam McLean

Illawarra cancer patients have been the first in the world to trial a new chemotherapy drug that’s proving more effective – and less toxic – than those currently available.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Taree news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.